Its tolerance and efficacy were proven under dermatological control on more than 200 subjects presenting mild to moderate blemishes, alone or in combination with medicinal treatments:
"KNOCK-OUT" ACTION after 7 days:
- 22% reduction of blemishes (1).
- 8 users in 10 are satisfied (2).
ANTI-RECURRENCE ACTION:
It is increasingly effective with every application:
- 45% reduction of blemishes as of 2 months(3), significant result vs the control group.
- 9 people in 10 show no recurrence of blemishes at 6 months (4).
EXCELLENT SKIN TOLERANCE
Suitable for pregnant women.
(1). 51 subjects presenting mild to moderate blemishes. Clinical score 2 applications per day for 56 days.
(2) 51 subjects presenting mild to moderate blemishes. Satisfaction survey. 2 applications per day for 56 days.
(3) 36 subjects presenting mild to moderate blemishes. Comparative clinical study (group treated 2 times/day N=18), control group (N=18) for 56 days.
(4) 48 subjects presenting mild to moderate blemishes. Clinical study, 90% of subjects without acne relapse at T6 months (according to the definition of relapse in the GEA protocol > or = 3 requiring the introduction of a medicinal treatment - oral or local). 2 applications per day for 6 months.
* Patent pending.